Sophia Chen
March 28, 2024
Novo Nordisk is pricing its diabetes treatment, Ozempic, at $1,000 a month in the US, a stark contrast to the $0.89 to $4.73 it costs to produce. This price difference underscores the substantial markup Novo Nordisk is applying, potentially hindering wider access to a drug proven effective for weight...